Insights

Market Leadership PharmaCielo is the largest licensed cannabis producer globally, with exclusive rights in Colombia for THC and CBD, positioning it as a key player in the rapidly expanding medical cannabis industry.

Global Expansion With operations rooted in both Canada and Colombia, PharmaCielo offers a diverse and scalable supply chain, providing opportunities to partner with large distributors, pharmaceutical companies, and manufacturers seeking high-quality, standardized cannabis extracts.

Production Capacity Access to over 110 million square feet of open-air greenhouse cultivation in Colombia presents significant potential for volume-based sales and partnerships with companies looking for reliable, high-volume producers.

Financial Position Although revenue remains modest at under $10 million, PharmaCielo has secured $3.5 million in funding, indicating growth prospects and potential for increased capacity and market penetration.

Technology Utilization The company's use of advanced digital tools such as AWS, Mura CMS, and Microsoft 365 demonstrates its modernization efforts, offering potential avenues for tech-driven supply chain or data management collaborations.

Similar companies to PharmaCielo

PharmaCielo Tech Stack

PharmaCielo uses 8 technology products and services including Amazon Web Services, RSS, Mura CMS, and more. Explore PharmaCielo's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • RSS
    Content Management System
  • Mura CMS
    Content Management System
  • Microsoft 365
    Email
  • jQuery UI
    Javascript Libraries
  • OWL Carousel
    Javascript Libraries
  • Slider Revolution
    Miscellaneous
  • Adobe ColdFusion
    Web Frameworks

PharmaCielo's Email Address Formats

PharmaCielo uses at least 1 format(s):
PharmaCielo Email FormatsExamplePercentage
F.Last@pharmacielo.comJ.Doe@pharmacielo.com
48%
FirstLast@pharmacielo.comJohnDoe@pharmacielo.com
2%
FirLast@pharmacielo.comJohDoe@pharmacielo.com
2%
F.Last@pharmacielo.comJ.Doe@pharmacielo.com
48%

Frequently Asked Questions

Where is PharmaCielo's headquarters located?

Minus sign iconPlus sign icon
PharmaCielo's main headquarters is located at Toronto, Ontario m5v 3b6 Canada. The company has employees across 4 continents, including South AmericaNorth AmericaEurope.

What is PharmaCielo's stock symbol?

Minus sign iconPlus sign icon
PharmaCielo is a publicly traded company; the company's stock symbol is PCLO.V.

What is PharmaCielo's official website and social media links?

Minus sign iconPlus sign icon
PharmaCielo's official website is pharmacielo.com and has social profiles on LinkedInCrunchbase.

What is PharmaCielo's SIC code NAICS code?

Minus sign iconPlus sign icon
PharmaCielo's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does PharmaCielo have currently?

Minus sign iconPlus sign icon
As of March 2026, PharmaCielo has approximately 108 employees across 4 continents, including South AmericaNorth AmericaEurope. Key team members include Cfo: S. L.Chief Financial Officer: I. A.President, Global Head Health & Innovation: D. H.. Explore PharmaCielo's employee directory with LeadIQ.

What industry does PharmaCielo belong to?

Minus sign iconPlus sign icon
PharmaCielo operates in the Pharmaceutical Manufacturing industry.

What technology does PharmaCielo use?

Minus sign iconPlus sign icon
PharmaCielo's tech stack includes Amazon Web ServicesRSSMura CMSMicrosoft 365jQuery UIOWL CarouselSlider RevolutionAdobe ColdFusion.

What is PharmaCielo's email format?

Minus sign iconPlus sign icon
PharmaCielo's email format typically follows the pattern of F.Last@pharmacielo.com. Find more PharmaCielo email formats with LeadIQ.

How much funding has PharmaCielo raised to date?

Minus sign iconPlus sign icon
As of March 2026, PharmaCielo has raised $3.5M in funding. The last funding round occurred on May 11, 2022 for $3.5M.

When was PharmaCielo founded?

Minus sign iconPlus sign icon
PharmaCielo was founded in 2014.

PharmaCielo

Pharmaceutical ManufacturingOntario, Canada51-200 Employees

Nature’s choice from Colombia. 

PharmaCielo Ltd. is the world’s largest licensed cannabis producer. We’re the first company to hold Colombian licences for unrestricted percentages of tetrahydrocannabinol (THC) and cannabidiol (CBD).

Our mission is to become the world’s leading supplier of naturally grown and processed, standardized medicinal-grade cannabis oil extracts and related products. PharmaCielo employs a B2B sales and distribution model targeting large channel distributors, finished goods manufacturers, research organizations and pharmaceutical companies.

PharmaCielo Ltd. is a global company headquartered in Ontario, Canada, chosen for the country’s standards of financial accountability and regulatory oversight.

PharmaCielo Colombia Holdings S.A.S., its wholly owned operating subsidiary, is headquartered in Rionegro, Colombia – a country with outstanding economic conditions, a clear legal framework for cannabis licensing and ideal climatic conditions. The company’s facility, combined with its contract growers’ space, offers access to 110.2 million square feet of open-air greenhouse cultivation capacity. 

The combination of the two countries – Canada and Colombia – is a winning structure for developing a sustainable international business model capable of capturing a significant share of the rapidly growing medical cannabis industry.

Section iconCompany Overview

Headquarters
Toronto, Ontario m5v 3b6 Canada
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
PCLO.V
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2014
Employees
51-200

Section iconFunding & Financials

  • $3.5M

    PharmaCielo has raised a total of $3.5M of funding over 6 rounds. Their latest funding round was raised on May 11, 2022 in the amount of $3.5M.

  • $1M$10M

    PharmaCielo's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $3.5M

    PharmaCielo has raised a total of $3.5M of funding over 6 rounds. Their latest funding round was raised on May 11, 2022 in the amount of $3.5M.

  • $1M$10M

    PharmaCielo's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.